Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation - PubMed (original) (raw)

. 1992 Jul 1;52(13):3687-92.

Affiliations

• PMID: 1319828

Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation

C Nervi et al. Cancer Res. 1992.

Abstract

The acute promyelocytic leukemia 15;17 chromosomal translocation fuses the PML gene to the RAR alpha locus. The resulting chimeric gene encodes for a putative PML-RAR alpha fusion protein. PML is a putative transcriptional factor and RAR alpha is one of the nuclear retinoic acid receptors through which retinoic acid regulates gene expression. In this study, we investigated the retinoid binding and biochemical properties of the PML-RAR alpha protein by size exclusion high-performance liquid chromatography and immunoblot analysis and compared them with those of normal RAR alpha. The introduction of the expression vector PSG5/PML-RAR alpha into COS-1 cells led to high levels of expression of the PML-RAR alpha fusion protein. This protein was primarily localized in the nucleus and bound retinoids with the same affinity and specificity as the wild type RAR alpha receptor. The PML-RAR alpha fusion protein, but not the RAR alpha, was found in high molecular weight complexes with either itself or other nuclear factors. In the acute promyelocytic leukemia-derived cell line NB4, which contains the t(15;17) chromosomal marker, the PML-RAR alpha product was also found as a high molecular complex. The interaction of the PML-RAR alpha with itself or with other nuclear proteins may be important in understanding the role of the PML-RAR alpha fusion protein in promyelocytic leukemogenesis.

PubMed Disclaimer

Similar articles

• Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
  Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S. Licht JD, et al. Oncogene. 1996 Jan 18;12(2):323-36. Oncogene. 1996. PMID: 8570209
• Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.
  Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LoCoco F, Grignani F, Pelicci PG. Pandolfi PP, et al. Oncogene. 1991 Jul;6(7):1285-92. Oncogene. 1991. PMID: 1650447
• [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
  Cornic M, Guidez F, Delva L, Agadir A, Degos L, Chomienne C. Cornic M, et al. Bull Cancer. 1992;79(7):697-704. Bull Cancer. 1992. PMID: 1334741 Review. French.
• The t(15;17) translocation in acute promyelocytic leukemia.
  Lavau C, Dejean A. Lavau C, et al. Leukemia. 1994 Oct;8(10):1615-21. Leukemia. 1994. PMID: 7934155 Review.

Cited by

• Alterations induced by the PML-RARα oncogene revealed by image cross correlation spectroscopy.
  Cerutti E, D'Amico M, Cainero I, Pelicci PG, Faretta M, Dellino GI, Diaspro A, Lanzanò L. Cerutti E, et al. Biophys J. 2022 Nov 15;121(22):4358-4367. doi: 10.1016/j.bpj.2022.10.003. Epub 2022 Oct 4. Biophys J. 2022. PMID: 36196056 Free PMC article.
• Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
  Beez S, Demmer P, Puccetti E. Beez S, et al. PLoS One. 2012;7(11):e48636. doi: 10.1371/journal.pone.0048636. Epub 2012 Nov 9. PLoS One. 2012. PMID: 23152790 Free PMC article.
• SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage.
  Tan JA, Sun Y, Song J, Chen Y, Krontiris TG, Durrin LK. Tan JA, et al. J Biol Chem. 2008 Jun 27;283(26):18124-34. doi: 10.1074/jbc.M800512200. Epub 2008 Apr 11. J Biol Chem. 2008. PMID: 18408014 Free PMC article.
• Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance.
  McNamara S, Wang H, Hanna N, Miller WH Jr. McNamara S, et al. Mol Cell Biol. 2008 Mar;28(6):2066-77. doi: 10.1128/MCB.01576-07. Epub 2008 Jan 22. Mol Cell Biol. 2008. PMID: 18212063 Free PMC article.
• Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
  Racanicchi S, Maccherani C, Liberatore C, Billi M, Gelmetti V, Panigada M, Rizzo G, Nervi C, Grignani F. Racanicchi S, et al. EMBO J. 2005 Mar 23;24(6):1232-42. doi: 10.1038/sj.emboj.7600593. Epub 2005 Feb 24. EMBO J. 2005. PMID: 15729358 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database